G. DeVincentis Sapienza University of Rome Rome (Italy)
Giuseppe De Vincentis, MD PhD, has more than 25 years experience in Nuclear Medicine . He has authored more than 140 peer-reviewed journal articles, 10 proceedings articles, more than 100 abstract several invited lectures, dealing with several fields of application of nuclear medicine techniques, such as cardiology, pneumology, muscular disease, oncology, clinical application of new imagers, therapeutical applications of alpha emitters nuclides (TaT). He is Associated Professor of Nuclear Medicine, Department of Radiological, Oncological and Pathological Sciences, at " Sapienza" University of Rome
A.R. Jalilian International Atomic Energy Agency (IAEA) Vienna (Austria)
Prof. Amir R. Jalilian has a PharmD. degree (1995), a PhD degree in Radiopharmacy (2000) followed by Postdoctoral fellowships from the University of Alberta, Canada and Yale School of Medicine, CT, USA. Until 2015, he was active in the development of new radiopharmaceuticals leading to the completion of clinical trials and the marketing of six radiopharmaceuticals. He has published around 300 scientific papers in peer-viewed journals and five books in various languages and supervised more than 50 MSc and PhD thesis. In 2015, he joined the Nuclear Sciences and Application Department, International Atomic Energy Agency (IAEA), Vienna Headquarters, Austria as a Radioisotope/Radiopharmaceutical Chemist. He is leading four IAEA international Collaborated Research Projects (CRP) on the topic of radioisotope and radiopharmaceutical production.
S. Muengtaweepongsa Thammasat University Bangkok (Thailand)
Dr.Sombat Muengtaweepongsa received his MD degree from the Ramathibodi Hospital Mahidol University, Bangkok, Thailand. And Dr. Muengtaweepongsa completed clinical fellowship training in Cerebrovascular and Critical care Neurology at the Saint Louis University, Missouri, USA. Dr. Muengtaweepongsa pursued an Academic career at the Department of Medicine, Faculty of Medicine, Thammasat University, as Associate Professor, Head of the Neurology Division (2008 - 2011), Chairman of the Department of Medicine (2011 – 2018) and Associate Dean for Research Affairs (2018-now). Dr. Muengtaweepongsa established the Stroke Fast Track and Stroke Unit (2008 - now) at Thammasat University Hospital where he served in Executive Director, Department Head positions focusing on stroke/CNS, thrombosis and targeted temperature management (TTM). Dr. Muengtaweepongsa is acknowledged for a pioneer of Stroke Network and Therapeutic Hypothermia for the treatment of Post-Cardiac Arrest and Critical Neurologic Conditions in Thailand. Dr. Muengtaweepongsa is listed on 2 patents, more than 20 edited books and authored and co-authored over 100 publications of which over 80 published in peer-reviewed scientific professional journals. Dr. Muengtaweepongsa served on editorial boards of many scientific journals (Journal of Interventional Neuroradiology, Frontiers in Neurology, World journal of Methodology). In the past 5 years, Dr. Muengtaweepongsa's work focused on research areas in Cerebrovascular and Critical care Neurology particularly targeted temperature management and stroke.
Sean L. Kitson Department of Biocatalysis and Isotope Chemistry Almac Sciences Almac House Craigavon (Northern Ireland)
Dr Kitson is an Investigator of Radiochemistry at Almac, UK. He has over 15 years of experience in the synthesis of carbon-14 labelled compounds. Dr Kitson is the Editor-in-Chief of Current Radiopharmaceuticals published by Bentham Science Publishers and the Journal of Diagnostic Imaging in Therapy. He has published over 45 research, reviews and commercial articles in the area of carbon-14 synthesis and medical imaging. His contribution to radiochemistry was acknowledged by winning the 2006 Wiley Journal of Labelled Compounds and Radiopharmaceuticals Young Scientists Award. Since, 2007 he has been a Member of the Scientific Committee for the International Isotopes Society (IIS) UK group.